article thumbnail

Antimicrobial Stewardship in the United kingdom: Perspective From A Pharmacist At A Bone & Joint Hospital

IDStewardship

In this article antimicrobial stewardship in the United Kingdom is discussed. Article posted 1 August 2022. Interview with: Tariq Azamgarhi, MRPharmS, PGDip Clin Pharm, PG CEPIP. Interview by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP.

Hospitals 147
article thumbnail

How to Improve Communication between Patient and Doctor?

Viseven

This article will discuss how to improve patient-clinician communication: basic principles, key advice, and main obstacles. . In this method, clinical personnel interacts with caregivers formally. The goal is to learn and write down up to five significant non-clinical management techniques and ideas for individualized care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What HCPs think about COVID-19’s impact on cancer

pharmaphorum

Prominent industry figures, such as oncologist and ex-director of the WHO Cancer Programme Professor Karol Sikora, shared news articles and utilised their networks to raise awareness of decreased cancer diagnosis. During the COVID-19 pandemic, delayed or decreased cancer diagnosis was highlighted by HCPs as a key concern.

Hospitals 123
article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

Given the proliferation and confusion of various digital health terms, this article includes a compiled glossary of core DHT terms and definitions (see Table 1). Category II: SaMD that provides information to drive clinical management of a disease or condition in a serious situation or condition and is considered to be of medium impact.

article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

Given the proliferation and confusion of various digital health terms, this article includes a compiled glossary of core DHT terms and definitions (see Table 1). Category II: SaMD that provides information to drive clinical management of a disease or condition in a serious situation or condition and is considered to be of medium impact.